Clinical trial
A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate…
NCT00234949 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00234949 |
|---|---|
| Title | A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections |
| Official title | A Comparative Study of the Safety, Tolerability, and Efficacy of Cefdinir and Cephalexin for the Treatment of Subjects With Mild to Moderate Uncomplicated Skin and Skin Structure Infections |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Mild to Moderate Uncomplicated Skin and Skin Structure Infections |
| Intervention type | Drug |
| Interventions | cefdinir, cephalexin |
| Enrollment | 380 |
| Start date | Mar 1, 2005 |
| First posted | Oct 10, 2005 |
| Last update posted | Oct 25, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: